Clinical Trial Update: Cisplatin or Carboplatin and Sorafenib in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating cisplatin or carboplatin in combination with sorafenib for unresectable liver cancer has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• CISPLATIN (cisplatin)
• Sorafenib (Sorafenib)

Snippet

Sponsor: University of Miami | Conditions: Liver Cancer | Phase 2 | Status: COMPLETED | Results posted: 2013-10-17